Been ranging since Dec 11th... 110 - 135.. EMA 50 is inching higher giving support from below.. Still LONG for this and accumulating in 110-115 range..
Heathcliff_
⋅
BRUSSELS, Dec 17 (Reuters) - The European Union has concluded preliminary talks with U.S. firm Novavax to secure up to 200 million doses of its COVID-19 vaccine candidate, a Commission spokesman said on Thursday.
"The envisaged contract foresees the possibility for member states to buy 100 million doses with the option of buying another 100 million doses," the spokesman said.
Heathcliff_
⋅
Dec 17 (Reuters) - Biotechnology company Novavax Inc said it had entered an agreement with the government of New Zealand for 10.7 million doses of its COVID-19 vaccine candidate.
"Under the terms of the agreement, Novavax will manufacture NVX-CoV2373 with a target of delivering initial doses by mid-2021", it said in a statement on Thursday.
The company will work with New Zealand's regulatory agency, Medsafe for approvals, it added. [nGNE9wTk7f]
Bobpnmicro
⋅
Are you high ? Company cannot get the phase III started in the US . Back to 80s shortly .
jacusroden
⋅
@Bobpnmicro, They already started phase III in U.S. It was only postponed a few weeks but they're in full capacity regarding phase III clinical trials with the results going to be released Q1 or in the very beginning of Q2 2021. Their vaccine - based on their propriety technology is far superior than the other companies such as Pfizer and Moderna, among others - its efficacy is higher and their vaccine also protects against genetic drift of the virus in case it mutates. They won't be first to market, but they will have the best and safest vaccine of all the other companies who rushed it to market and ignored the side effects pretending there are none. MRNA vaccines have never been tested on humans before so no one knows the long term consequences if there are any as no long term studies have been conducted. Also they can produce their vaccine in larger and faster quantities since their vaccine is based on recombinant technology and is not egg based like Pfizer and Moderna. They also have a lot of medically crucial drugs in their pipeline most of them ready or very close to phase 3 trials. Novavax will skyrocket. The other companies don't care if any serious adverse reactions or damage happen to the the people who get the vaccine - they only care about profits which will be in the high billions which will be payed by the taxpayer. So they receive money on top of money. Greed and profits are more important than ethics and safety. They also have signed deals with certain major countries to supply their vaccine.
Bobpnmicro
⋅
@jacusroden, That maybe true my friend but there are three risks .
Risk 1 :
The pharma giants pretty much own the FDA and the media . As you can see Novavax is often ignored and never gets a big headline . If you remember correctly after their phase I resultS CNBC'S Meg Tirrel did not talk about their great data but only paid attention to wild swings in their stock AH as a result of misinformation ( Compare that to the coverage of AZN, PFE and MRNA) .The more this goes on, the weaker the charts gets. The chart is already flirting with support and needs lifeblood ASAP .
Risk 2 :
Extremely overvalued companies like MRNA , CVAC , BNTX ... could cause a selloff in the sector and that leaves NVAX vulnerable . The lack of PR and news from the company is leaving things very shaky.
Risk 3 :
The stock is extremely volatile and could get down to $70-$80 purely on PFE , MRNA approval and momentum/lack of news . It could gain 40 percent on its Phase III interim data but that could be on a beaten down price like $75 . So $75 to $105 you d still lose a significant amount of money if you get in now .
THAT'S WHY THEIR MULTIPLE DELAYS AND TERRIBLE PR MAKES THIS AN EXTREMELY RISKY PLAY .
Bobpnmicro
⋅
@Bobpnmicro, I will gladly admit I was wrong and fully admit defeat . NVAX is here to stay .
Bobpnmicro
⋅
@jacusroden, I will gladly admit I was wrong and admit defeat . Novavax NVAX is here to stay and maybe stronger than ever .
Heathcliff_
⋅
@Bobpnmicro, Not counting my chickens yet.. Let’s see in month or two. Good points with the risks.